Immunotherapeutic Concepts to Target Acute Myeloid Leukemia: Focusing on the Role of Monoclonal Antibodies, Hypomethylating Agents and the Leukemic Microenvironment

Intensive chemotherapeutic protocols and allogeneic stem cell transplantation continue to represent the mainstay of acute myeloid leukemia (AML) treatment. Although this approach leads to remissions in the majority of patients, long-term disease control remains unsatisfactory as mirrored by overall...

Descripción completa

Detalles Bibliográficos
Autores principales: Gbolahan, Olumide Babajide, Zeidan, Amer M., Stahl, Maximilian, Abu Zaid, Mohammad, Farag, Sherif, Paczesny, Sophie, Konig, Heiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578050/
https://www.ncbi.nlm.nih.gov/pubmed/28758974
http://dx.doi.org/10.3390/ijms18081660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578050/
https://www.ncbi.nlm.nih.gov/pubmed/28758974
http://dx.doi.org/10.3390/ijms18081660

Ejemplares similares